{"nct_id":"NCT05477563","title":"Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease","status":"RECRUITING","status_verified_date":"2025-03","start_date":"2022-08-02","start_date_type":"ACTUAL","primary_completion_date":"2027-06-09","primary_completion_date_type":"ESTIMATED","completion_date":"2027-06-09","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["VRTX"]}